APOC2 and chronic kidney disease: Although the mechanism underlying CVD attributed to apoC-II and apoC-III has not yet been fully elucidated, our results shed new light on the links between apoC-II, apoC-III, lipoproteins, and CV risk markers in children with mild-to-moderate CKD.